- 同
- MIP-1oc
- 同
- MIP-1oc
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2018/09/08 18:13:03」(JST)
[Wiki en表示]
For the aerodrome using the TC LID, CCL3, see Christina Lake Aerodrome.
CCL3 |
---|
|
Available structures |
---|
PDB | Human UniProt search: PDBe RCSB |
---|
List of PDB id codes |
---|
1B50, 1B53, 2X69, 2X6G, 3FPU, 3H44, 3KBX, 4RA8, 4ZKB, 5D65, 5COR |
|
|
Identifiers |
---|
Aliases | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3, C-C motif chemokine ligand 3 |
---|
External IDs | OMIM: 182283 HomoloGene: 88430 GeneCards: CCL3 |
---|
Gene location (Human) |
---|
| Chr. | Chromosome 17 (human)[1] |
---|
| Band | 17q12 | Start | 36,088,256 bp[1] |
---|
End | 36,090,169 bp[1] |
---|
|
RNA expression pattern |
---|
| More reference expression data |
|
Gene ontology |
---|
Molecular function | • protein kinase activity • cytokine activity • CCR5 chemokine receptor binding • chemokine activity • CCR1 chemokine receptor binding • kinase activity • phospholipase activator activity • calcium-dependent protein kinase C activity • protein binding • identical protein binding • chemoattractant activity
|
---|
Cellular component | • cytoplasm • cytosol • intracellular • extracellular region • extracellular space
|
---|
Biological process | • G-protein coupled receptor signaling pathway • signaling • negative regulation of bone mineralization • positive regulation of protein kinase B signaling • release of sequestered calcium ion into cytosol by sarcoplasmic reticulum • response to cholesterol • positive regulation of calcium-mediated signaling • regulation of sensory perception of pain • protein kinase B signaling • monocyte chemotaxis • negative regulation of osteoclast differentiation • astrocyte cell migration • positive regulation of cell migration • positive regulation of natural killer cell chemotaxis • chemokine-mediated signaling pathway • T cell chemotaxis • cell-cell signaling • cellular response to tumor necrosis factor • eosinophil chemotaxis • cellular response to organic cyclic compound • cellular calcium ion homeostasis • negative regulation of gene expression • neutrophil chemotaxis • cell activation • MAPK cascade • chemotaxis • positive regulation of GTPase activity • positive regulation of neuron apoptotic process • positive regulation of calcium ion import • macrophage chemotaxis • positive regulation of gene expression • cytoskeleton organization • positive regulation of interleukin-1 beta secretion • osteoblast differentiation • cellular response to interleukin-1 • immune response • positive regulation of ERK1 and ERK2 cascade • regulation of cell shape • positive regulation of tumor necrosis factor production • cellular response to interferon-gamma • lymphocyte chemotaxis • inflammatory response • granulocyte chemotaxis • response to toxic substance • eosinophil degranulation • lipopolysaccharide-mediated signaling pathway • calcium ion transport • calcium-mediated signaling • exocytosis • positive regulation of calcium ion transport • positive chemotaxis • positive regulation of inflammatory response • regulation of receptor activity • cytokine-mediated signaling pathway • regulation of behavior
|
---|
Sources:Amigo / QuickGO |
|
Orthologs |
---|
Species | Human | Mouse |
---|
Entrez | | |
---|
Ensembl | |
---|
ENSG00000278567 ENSG00000277632 ENSG00000274221 |
| |
---|
UniProt | | |
---|
RefSeq (mRNA) | | |
---|
RefSeq (protein) | | |
---|
Location (UCSC) | Chr 17: 36.09 – 36.09 Mb | n/a |
---|
PubMed search | [2] | n/a |
---|
Wikidata |
|
Chemokine (C-C motif) ligand 3 (CCL3) also known as macrophage inflammatory protein 1-alpha (MIP-1-alpha) is a protein that in humans is encoded by the CCL3 gene.[3]
Function
CCL3 is a cytokine belonging to the CC chemokine family that is involved in the acute inflammatory state in the recruitment and activation of polymorphonuclear leukocytes[4] through binding to the receptors CCR1, CCR4 and CCR5.[3]
Sherry et al. (1988) demonstrated 2 protein components of MIP1, called by them alpha (CCL3, this protein) and beta (CCL4).[5][3]
CCL3 produces a monophasic fever of rapid onset whose magnitude is equal to or greater than that of fevers produced with either recombinant human tumor necrosis factor or recombinant human interleukin-1. However, in contrast to these two endogenous pyrogens, the fever induced by MIP-1 is not inhibited by the cyclooxygenase inhibitor ibuprofen and CCL3 may participate in the febrile response that is not mediated through prostaglandin synthesis and clinically cannot be ablated by cyclooxygenase.[6]
Interactions
CCL3 has been shown to interact with CCL4.[7]
Attracts macrophages, monocytes and neutrophils.
See also
- Macrophage inflammatory proteins
References
- ^ a b c ENSG00000277632, ENSG00000274221 GRCh38: Ensembl release 89: ENSG00000278567, ENSG00000277632, ENSG00000274221 - Ensembl, May 2017
- ^ "Human PubMed Reference:".
- ^ a b c "Entrez Gene: CCL3 chemokine (C-C motif) ligand 3".
- ^ Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A (1988). "Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties". The Journal of Experimental Medicine. 167 (2): 570–81. doi:10.1084/jem.167.2.570. PMC 2188834 . PMID 3279154.
- ^ Sherry B, Tekamp-Olson P, Gallegos C, Bauer D, Davatelis G, Wolpe SD, Masiarz F, Coit D, Cerami A (1988). "Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta". The Journal of Experimental Medicine. 168 (6): 2251–9. doi:10.1084/jem.168.6.2251. PMC 2189160 . PMID 3058856.
- ^ Davatelis G, Wolpe SD, Sherry B, Dayer JM, Chicheportiche R, Cerami A (1989). "Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen". Science. 243 (4894 Pt 1): 1066–8. doi:10.1126/science.2646711. PMID 2646711.
- ^ Guan E, Wang J, Norcross MA (Apr 2001). "Identification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimer". The Journal of Biological Chemistry. 276 (15): 12404–9. doi:10.1074/jbc.M006327200. PMID 11278300.
External links
- Human CCL3 genome location and CCL3 gene details page in the UCSC Genome Browser.
Further reading
- Menten P, Wuyts A, Van Damme J (Dec 2002). "Macrophage inflammatory protein-1". Cytokine & Growth Factor Reviews. 13 (6): 455–81. doi:10.1016/S1359-6101(02)00045-X. PMID 12401480.
- Muthumani K, Desai BM, Hwang DS, Choo AY, Laddy DJ, Thieu KP, Rao RG, Weiner DB (Apr 2004). "HIV-1 Vpr and anti-inflammatory activity". DNA and Cell Biology. 23 (4): 239–47. doi:10.1089/104454904773819824. PMID 15142381.
- Joseph AM, Kumar M, Mitra D (Jan 2005). "Nef: "necessary and enforcing factor" in HIV infection". Current HIV Research. 3 (1): 87–94. doi:10.2174/1570162052773013. PMID 15638726.
- Zhao RY, Elder RT (Mar 2005). "Viral infections and cell cycle G2/M regulation". Cell Research. 15 (3): 143–9. doi:10.1038/sj.cr.7290279. PMID 15780175.
- Zhao RY, Bukrinsky M, Elder RT (Apr 2005). "HIV-1 viral protein R (Vpr) & host cellular responses". The Indian Journal of Medical Research. 121 (4): 270–86. PMID 15817944.
- Li L, Li HS, Pauza CD, Bukrinsky M, Zhao RY (2006). "Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions". Cell Research. 15 (11–12): 923–34. doi:10.1038/sj.cr.7290370. PMID 16354571.
PDB gallery |
---|
1b50: NMR STRUCTURE OF HUMAN MIP-1A D26A, 10 STRUCTURES 1b53: NMR STRUCTURE OF HUMAN MIP-1A D26A, MINIMIZED AVERAGE STRUCTURE |
Cell signaling: cytokines |
---|
By family | Chemokine | CCL |
- CCL1
- CCL2/MCP1
- CCL3/MIP1α
- CCL4/MIP1β
- CCL5/RANTES
- CCL6
- CCL7
- CCL8
- CCL9
- CCL11
- CCL12
- CCL13
- CCL14
- CCL15
- CCL16
- CCL17
- CCL18/PARC/DCCK1/AMAC1/MIP4
- CCL19
- CCL20
- CCL21
- CCL22
- CCL23
- CCL24
- CCL25
- CCL26
- CCL27
- CCL28
|
---|
CXCL |
- CXCL1/KC
- CXCL2
- CXCL3
- CXCL4
- CXCL5
- CXCL6
- CXCL7
- CXCL8/IL8
- CXCL9
- CXCL10
- CXCL11
- CXCL12
- CXCL13
- CXCL14
- CXCL15
- CXCL16
- CXCL17
|
---|
CX3CL | |
---|
XCL | |
---|
|
---|
TNF |
- TNFA
- Lymphotoxin
- TNFSF4
- TNFSF5/CD40LG
- TNFSF6
- TNFSF7
- TNFSF8
- TNFSF9
- TNFSF10
- TNFSF11
- TNFSF13
- TNFSF13B
- EDA
|
---|
Interleukin | Type I (grouped by receptor subunit) | γ chain |
- IL2/IL15
- IL4/IL13
- IL7
- IL9
- IL21
|
---|
β chain | |
---|
IL6 like/gp130 |
- IL6
- IL11
- IL27
- IL30
- IL31
- +non IL OSM
- LIF
- CNTF
- CTF1
|
---|
IL12 family/IL12RB1 | |
---|
Other | |
---|
|
---|
Type II | IL10 family |
- IL10/IL22
- IL19
- IL20
- IL24
- IL26
- Interferon type III
|
---|
Interferon | I |
- IFNA1
- IFNA2
- IFNA4
- IFNA5
- IFNA6
- IFNA7
- IFNA8
- IFNA10
- IFNA13
- IFNA14
- IFNA16
- IFNA17
- IFNA21
- IFNB1
- IFNK
- IFNW1
|
---|
II | |
---|
|
---|
|
---|
Ig superfamily |
- IL1 family: IL1A/IL1F1
- IL1B/IL1F2
- 1Ra/IL1F3
- IL1F5
- IL1F6
- IL1F7
- IL1F8
- IL1F9
- IL1F10
- 33/IL1F11
- 18/IL1G
|
---|
IL17 family | |
---|
|
---|
Other |
- Hematopoietic
- KITLG
- Colony-stimulating factor
- SPP1
- MIF
|
---|
|
---|
By function/ cell | |
---|
Chemokine receptor modulators |
---|
CC | CCR1 |
- Agonists: CCL4 (MIP-1β)
- CCL5 (RANTES)
- CCL6
- CCL9 (CCL10)
- CCL14
- CCL15
- CCL16
- CCL23
|
---|
CCR2 |
- Agonists: CCL2
- CCL8
- CCL12
- CCL16
- NAMs: Cenicriviroc (TAK-652, TBR-652)
|
---|
CCR3 |
- Agonists: CCL5 (RANTES)
- CCL7
- CCL11
- CCL13
- CCL15
- CCL18
- CCL24
- CCL26
- CCL28
|
---|
CCR4 |
- Agonists: CCL3 (MIP-1α)
- CCL5 (RANTES)
- CCL17
- CCL22
- Antibodies: Mogamulizumab (against CCR4)
|
---|
CCR5 |
- Agonists: CCL3 (MIP-1α)
- CCL4 (MIP-1β)
- CCL5 (RANTES)
- CCL8
- CCL11
- CCL13
- CCL14
- CCL16
- NAMs: Aplaviroc
- Cenicriviroc (TAK-652, TBR-652)
- INCB009471
- Maraviroc
- Vicriviroc
|
---|
CCR6 | |
---|
CCR7 | |
---|
CCR8 | |
---|
CCR9 | |
---|
CCR10 | |
---|
CCR11 |
- Agonists: CCL19
- CCL21
- CCL25
|
---|
Ungrouped |
- Antibodies: Bertilimumab (against CCL11)
- Carlumab (against CCL2)
|
---|
|
---|
CXC | CXCR1 (IL-8Rα) |
- Agonists: CXCL6
- Emoctakin
- Interleukin-8 (CXCL8, GCP-1)
- NAMs: Ladarixin
- Reparixin (repertaxin)
|
---|
CXCR2 (IL-8Rβ) |
- Agonists: CXCL1 (MGSA)
- CXCL2
- CXCL3
- CXCL5
- CXCL6
- CXCL7
- Emoctakin
- Garnocestim
- Interleukin-8 (CXCL8, GCP-1)
- Antagonists: Danirixin
- Elubrixin
- Navarixin
- NAMs: Ladarixin
- Reparixin (repertaxin)
|
---|
CXCR3 |
- Agonists: CXCL4 (PF4)
- CXCL9 (MIG)
- CXCL10 (IP-10)
- CXCL11 (I-TAC)
- Iroplact
- Antibodies: Eldelumab (against CXCL10)
|
---|
CXCR4 |
- Agonists: MIF
- SDF-1 (CXCL12)
- Ubiquitin
- Antagonists: Mavorixafor
- Plerixafor (AMD3100)
- Antibodies: Ulocuplumab (against CXCR4)
|
---|
CXCR5 | |
---|
CXCR6 | |
---|
CXCR7 |
- Agonists: CXCL11 (I-TAC)
- SDF-1 (CXCL12)
- PAMs: Plerixafor (AMD3100)
|
---|
|
---|
C (XC) | XCR1 |
- Agonists: Lymphotactin-α (XCL1)
- Lymphotactin-β (XCL2)
|
---|
|
---|
CX3C | CX3CR1 |
- Agonists: Fractalkine (CX3CL1)
|
---|
|
---|
Others | CCBP2 |
- Agonists: CC (β) chemokines
|
---|
CMKLR1 |
- Agonists: Chemerin
- Resolvin E1
|
---|
|
---|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Cytokine receptor modulators
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Hepatic topographical changes of endoplasmic reticulum stress and unfolded protein response signaling after hemorrhagic shock and reperfusion.
- Wolpert A1, Obert D2, Frey B2, Lee YS3, Korff S2.
- The Journal of surgical research.J Surg Res.2018 Nov;231:278-289. doi: 10.1016/j.jss.2018.05.060. Epub 2018 Jun 23.
- PMID 30278941
- The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.
- Staversky RJ1, Byun DK1, Georger MA2, Zaffuto BJ2, Goodman A1, Becker MW1,3, Calvi LM1,2,3,4, Frisch BJ5,6,7.
- Scientific reports.Sci Rep.2018 Oct 2;8(1):14691. doi: 10.1038/s41598-018-32978-y.
- PMID 30279500
- Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice.
- Vanheule V1, Crijns H1, Poosti F1, Ruytinx P1, Berghmans N1, Gerlza T2,3, Ronsse I1, Pörtner N1, Matthys P4, Kungl AJ2,3, Opdenakker G4, Struyf S1, Proost P1.
- Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.Clin Exp Allergy.2018 Oct;48(10):1333-1344. doi: 10.1111/cea.13227. Epub 2018 Aug 14.
- PMID 29978510
Japanese Journal
- Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice
- Sasaki Soichiro,Baba Tomohisa,Shinagawa Kei,Matsushima Kouji,Mukaida Naofumi
- International Journal of Cancer 135(6), 1297-1306, 2014-09-15
- … AOM/DSS-induced tumor formation was reduced in CCL3- or its specific receptor, CCR5-deficient mice despite the presence of a massive infiltration of inflammatory cells. … However, AOM/DSS-induced type I collagen-positive fibroblast accumulation in the colon was reduced in CCL3- or CCR5-deficient mice. … Moreover in vitro, CCL3 induced fibroblasts to proliferate and to enhance HB-EGF expression. …
- NAID 120005463351
- Differences in the Toxicities of Trichothecene Mycotoxins, Deoxynivalenol and Nivalenol, in Cultured Cells
- NAGASHIMA Hitoshi,NAKAGAWA Hiroyuki
- Japan Agricultural Research Quarterly: JARQ 48(4), 393-397, 2014
- … While exposure to DON significantly induced the secretion of anti-hematopoietic cytokines macrophage inflammatory protein-1α (MIP-1α/CCL3) and MIP-1β/CCL4, treatment with NIV decreased the secretion of these cytokines in HL60 cells, indicating that the toxicity mechanisms of these toxins differ. …
- NAID 130004701841
- Lactobacillus acidophilus L-92 Cells Activate Expression of Immunomodulatory Genes in THP-1 Cells
- YANAGIHARA Sae,GOTO Hiroaki,HIROTA Tatsuhiko,FUKUDA Shinji,OHNO Hiroshi,YAMAMOTO Naoyuki
- Bioscience of Microbiota, Food and Health 33(4), 157-164, 2014
- … In the early phase of L-92 treatment, various transcription regulator genes, such as, NFkB1, NFkB2, JUN, HIVEP2 and RELB, and genes encoding chemokines and cytokines, such as CCL4, CXCL11, CCL3 and TNF, were upregulated. …
- NAID 130004680094
Related Pictures
★リンクテーブル★
[★]
- 英
- [[]]
- 関
- CCL3
- 関
- CCL3
[★]
- 英
- chemokine CCL3
- 関
- マクロファージ炎症性タンパク質1α
[★]
ケモカインCCL3
- 関
- MIP-1alpha
[★]
[★]
セファクロル cefaclor